Vaccines Market, by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), Route (IM, SC, ID, Oral), Patient (Pediatric, Adult), Type and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global vaccines market size is projected to reach USD 62 billion by 2026 at a CAGR of 8.2% from USD 45 billion in 2021 during the forecast period 2021-2028.
Vaccine is a biologically processed preparation which is used to achieve acquired immunity regarding a particular infectious disease. It can be used as both a prevention and cure depending on the nature of the causative nature of the infectious disease. Edward Jenner was the first person who came up with the term vaccine and also manufacture the first vaccine against the infectious disease small pox.
Due to the increasing number of infectious diseases along with the governmental focus on the immunization process and the efforts by the industries in the direction are some of the factors that have supported long-term expansion for Vaccines Market.
The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. But the market of vaccines has seen a boom during the pandemic owing to the viral cause of the disease.
North America is expected to be the largest market during the forecast period. Due to the high prevalence of infectious disease in the region along with the increased investment ibn the sector by both governmental and non-governmental organizations has led to the expansion of the market in the region.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 45 billion |
Growth Rate |
CAGR of 8.2% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD million and CAGR from 2021 to 2028 |
Report Segmentation |
Technology, type, disease indication, route of administration, patient type and geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
GlaxoSmithKline plc , Pfizer, Inc. , Sanofi Pasteur , Merck & Co., Inc. , CSL Limited (Australia), Emergent BioSolutions, Inc. , Johnson & Johnson , AstraZeneca , Serum Institute of India Pvt. Ltd. , Bavarian Nordic , Mitsubishi Tanabe Pharma Corporation , Daiichi Sankyo Company, Limited , Panacea Biotec , Biological E , Bharat Biotech , Sinovac Biotech Ltd., Incepta Vaccine Ltd. , Valneva SE , VBI Vaccines Inc. , and PT Bio Farma |
Available Customization |
In addition to the market data for Vaccines Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Vaccines Market is segmented into Technology, type, disease indication, route of administration, patient type and geography.